FY2025 · ended Dec 31, 2025 · Revenue $747,000, +1637.2% YoY · Filed Mar 30, 2026
Bio Green Med Solution, Inc. (BGMS) files with the SEC under industry code 5099, Wholesale-Durable Goods, NEC. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $747,000 and a net loss of $3.0 million. As of Jun 30, 2026 it held $3.8 million in cash and investments and $2,000 in total debt.
Revenue (TTM)
$1.83M
Net income (TTM)
$-2.20M
Operating cash flow (TTM)
$-1.10M
Free cash flow
$-16.12M
+22.6% vs prior year
EPS
$-6.45
+98.7% vs prior year
Dividend per share
None
Shares outstanding
5.52M
+538.9% vs prior year
Net cash
$3.79M
as of Jun 30, 2026
Operating margin
-198.5%
FY 2026
Company profile
- Industry
- Wholesale-Durable Goods, NEC (SIC 5099)
- Listed as
- BGMS (Nasdaq), BGMSP (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Berkeley Heights, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1130166
- Former names
- Cyclacel Pharmaceuticals, Inc. (until Sep 12, 2025); XCYTE THERAPIES INC (until Mar 24, 2006)
Other Wholesale-Durable Goods, NEC companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $747,000 | $43,000 | $420,000 | $0 | $0 |
| Operating income | -$8.4M | -$12.0M | -$25.5M | -$27.7M | -$22.4M |
| Net income | -$3.0M | -$11.2M | -$22.6M | -$21.2M | -$18.5M |
| Diluted EPS | -$6.45 | -$502.46 | — | -$27.24 | -$2.09 |
| Operating cash flow | -$4.8M | -$8.0M | -$16.1M | -$20.8M | -$18.5M |
| Free cash flow | — | — | -$16.1M | -$20.8M | -$18.6M |
| Total assets | $8.2M | $4.1M | $8.8M | $28.1M | $43.1M |
| Total liabilities | $1.3M | $6.3M | $8.2M | $7.6M | $5.4M |
| Stockholders' equity | $6.8M | -$2.2M | $607,000 | $15.9M | $37.7M |
| Cash and investments | $3.5M | $3.1M | $3.4M | $22.9M | $41.0M |
| Total debt | $20,000 | $5,000 | $37,000 | $106,000 | $30,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Listing notice
|
Nov 4, 2026 | Oct 29, 2026 |
| 8-K |
Current report
Other events
|
Oct 16, 2026 | Oct 16, 2026 |
| 10-Q | Quarterly report | Aug 14, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 14, 2026 | Aug 12, 2026 |
| 8-K |
Current report
Other events
|
Jul 1, 2026 | Jul 1, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 22, 2026 | Jun 18, 2026 |
All 1000 Bio Green Med Solution, Inc. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.